Call Options Transactions Made in Q4 2022 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q4 2022. The information is specifically focused on institutions that hold call options of Revance Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Antara Capital LP
New York, NY |
BUY
|
CALL |
1.17M+ 28.76% |
$21.4M - $35.9M
|
5.24M
$13.5M
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
353K+ 125.07% |
$6.47M - $10.8M
|
636K
$1.63M
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
CALL |
270KNew |
$4.95M - $8.28M
|
270K
$694K
|
|
|
Feb 14, 2023
Q4 2022
|
Tri Locum Partners LP
New York, NY |
BUY
|
CALL |
166KNew |
$3.05M - $5.1M
|
166K
$427K
|
|
|
Feb 14, 2023
Q4 2022
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
18.6K+ 432.56% |
$341K - $570K
|
22.9K
$58.9K
|
|
|
Feb 07, 2023
Q4 2022
|
Cutler Group LP
|
SELL
|
CALL |
-19.4K- 80.83% |
$355K - $595K
|
4.6K
$11.8K
|
|
|
Feb 14, 2023
Q4 2022
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-24.2K- 41.87% |
$443K - $742K
|
33.6K
$86.4K
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-311K- 69.63% |
$5.69M - $9.52M
|
136K
$348K
|
|
|
Feb 14, 2023
Q4 2022
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-315K- 27.16% |
$5.78M - $9.67M
|
846K
$2.17M
|
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
CALL |
-1.52M- 83.49% |
$27.8M - $46.5M
|
300K
$771K
|